These strategies remain entirely preclinical, with ongoing efforts focused on mechanistic validation and delivery feasibility
Cost Range : $200-$500 per session, with specialized COVID recovery formulations typically in the $300-475 range
Investigated in rodent and non-human primate models of diet-induced obesity, hepatic steatosis and glycaemic dysregulation
Its strengths include peer-reviewed clinical outcomes, comprehensive lab monitoring, dedicated dietitian access, and employer-covered pricing
These additional pathways are not workarounds they are legitimate FDA-approved indications
6 Emerging clinical applications 6.1 Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) Studies investigating GLP-1 receptor agonists for the prevention of NAFLD/NASH indicate potential effectiveness via several molecular mechanisms